327 Editor's Choice - December 2018 P. Saunderson


328 Severe adverse reactions to multidrug therapy for leprosy, registered in tertiary services between 2012 and 2017 in Brazil C.C Pante, S.C. Caelho, L.Carelli, J. Avancini and M.A.B Trinidade

335 A single dose of rifampicin to prevent leprosy: qualitative analysis of perceptions of people affected, contacts, community members and health professionals towards chemoprophylaxis and the impact on their attitudes in India, Nepal and Indonesia R. Peters, L. Mieras, M. Subedi, H. Apete, T. Koesbardiati, N.L. Banstola, S. Das and W. Van Brakel

353 Burden of leprosy related disability: results of a population survey in two states in India A. Kumar, S. Husain and B.N. Murphy

362 Stigma and leprosy presentations, Nepal U.B. Engelbrektsson and M. Subedi

370 Histopathological findings in nerve biopsies from patients suspected with pure neural leprosy in two teaching hospitals in Mumbai in the period 2008-2015 V.P. Shetty, A. Khodke, S. Khadilkar and M. Thatte

376 Sensitivity of Anti-PGL-1 Elisa test using mixed antigens (disaccharide and trisaccharide) for the diagnosis and epidemiological surveillance of leprosy M.D.P.S.A Silvestre, M.F. De Lima and L.N.G.C Lima

387 The expression of Th17/ Treg cells in skin lesions during leprosy and its clinical significance J. Wang, G. Zhang, Q. Yao, H. Shen, X. Yu, Q. Chen and H. Chen


395 Unusual presentation of an uncommon disease A. Singh, G. Bhatia, A. Mehan, H. Chandra and R. Kant


399 Diagnosis of leprosy C.R. Butlin